BDTX
NASDAQ · Biotechnology
Black Diamond Therapeutics I
$1.61
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,131.1% upside
Low Target
$30.62
Average Target
$35.92
High Target
$44.24
Current Price
$1.61
Current
$1.61
$1.61
Target
$35.92
$35.92
$30.62
$35.92 avg
$44.24
Scenario Analysis
Bear Case
$30.62
1,801.9%
Low target
Base Case
$35.92
+2,131.1%
Avg target
Bull Case
$44.24
+2,647.8%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$4.94
-67.4% from high
52-Week Low
$1.60
+0.6% from low
Target vs 52W High
$35.92
+627.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |